FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Clinical trials for FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a hormonal IUD replace surgery for some uterine cancers?
Disease control OngoingThis study tests whether a hormonal intrauterine device (IUD) alone or combined with the drug everolimus can treat precancerous changes or early-stage, low-grade endometrial cancer. About 102 participants will receive the IUD, and if it doesn't work after 3 months, some also get …
Matched conditions: FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New combo therapy aims to slow advanced endometrial cancer
Disease control OngoingThis study tests whether adding the drug ipatasertib to standard hormone therapy (megestrol acetate) is safer and works better than hormone therapy alone for people with recurrent or metastatic endometrioid endometrial cancer. About 96 participants with grade 1 or 2 cancer that h…
Matched conditions: FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New combo aims to outsmart Drug-Resistant ovarian cancer
Disease control OngoingThis early-phase trial tests a new drug (peposertib) combined with standard chemotherapy (PLD) in people with ovarian or related cancers that no longer respond to platinum-based treatment. The main goal is to find the safest dose and check for side effects. About 54 participants …
Matched conditions: FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Remote exercise program aims to boost strength in rural cancer survivors
Symptom relief OngoingThis study tests a 10-week home exercise program for endometrial cancer survivors who live in rural areas or are from underserved groups. Participants do strength training twice a week using a video call. The goal is to see if the program is practical and helps improve physical f…
Matched conditions: FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 15, 2026 12:07 UTC
-
New study aims to predict cancer return in low-risk patients
Knowledge-focused OngoingThis study looks at whether molecular testing and lymph node mapping can help predict if low-risk endometrial cancer will return after surgery. About 518 patients with early-stage, low-grade cancer will be followed for two years. The goal is to improve follow-up care by identifyi…
Matched conditions: FIGO GRADE 2 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:32 UTC